Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Conbercept by Chengdu Kanghong Pharmaceuticals Group for Retinoblastoma: Likelihood of Approval
Conbercept is under clinical development by Chengdu Kanghong Pharmaceuticals Group and currently in Phase II for Retinoblastoma. According to GlobalData,...
Data Insights
Conbercept by Chengdu Kanghong Pharmaceuticals Group for Branch Retinal Vein Occlusion: Likelihood of Approval
Conbercept is under clinical development by Chengdu Kanghong Pharmaceuticals Group and currently in Phase III for Branch Retinal Vein Occlusion....